Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study
CNS Neuroscience & Therapeutics,  Clinical Article

Koliaki CC et al. – The findings indicate that aniracetam (a nootropic compound with glutamatergic activity and neuroprotective potential) is a promising option for patients with cognitive deficit of mild severity. It preserved all neuropsychological parameters for at least 12 months, and seemed to exert a favorable effect on emotional stability of demented patients.

Methods
  • In the prospective, open–label study, the authors enrolled a total of 276 patients (mean age 71 ± 8 years, 95 males) with cognitive disorders.
  • The study population comprised four groups: no treatment group (n=75), aniracetam monotherapy group (n=58), ChEIs monotherapy group (n=68), and group of combined treatment (n=68).
  • Patients were examined with validated neuropsychological tests at baseline, 3, 6, and 12 months of treatment.

Results
  • In patients treated with aniracetam, all studied parameters were adequately maintained at 6 and 12 months, while emotional state was significantly improved at 3 months.
  • In patients treated with ChEIs, they observed a significant cognitive deterioration at 12 months.
  • The comparison between aniracetam and ChEIs in patients with relatively mild dementia (15 ≤MMSE ≤25) revealed a significantly better cognitive performance with aniracetam at 6 months and improved functionality at 3 months.
  • Comparing aniracetam monotherapy with combined treatment in the same population, aniracetam performed better in the cognitive scale at 6 months, and displayed a notable tendency for enhanced mood at 12 months and improved functionality at 6 months.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close